Big Pharma prefers medicines with a defined mode of action (MoA). It eases regulatory approval, reimbursement by public insurance, marketing, and communication with the physicians. Side effects are accepted as collateral damages. Studies for the approval of new topical eye drops frequently compare the new drug with its vehicle (i.e. the drug formulation without the … Continue reading Homeostasis of the Ocular Surface